These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25685685)

  • 1. GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo.
    Hauge M; Vestmar MA; Husted AS; Ekberg JP; Wright MJ; Di Salvo J; Weinglass AB; Engelstoft MS; Madsen AN; Lückmann M; Miller MW; Trujillo ME; Frimurer TM; Holst B; Howard AD; Schwartz TW
    Mol Metab; 2015 Jan; 4(1):3-14. PubMed ID: 25685685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gq and Gs signaling acting in synergy to control GLP-1 secretion.
    Hauge M; Ekberg JP; Engelstoft MS; Timshel P; Madsen AN; Schwartz TW
    Mol Cell Endocrinol; 2017 Jul; 449():64-73. PubMed ID: 27908836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free fatty acid receptor 1 stimulates cAMP production and gut hormone secretion through Gq-mediated activation of adenylate cyclase 2.
    Petersen JE; Pedersen MH; Dmytriyeva O; Nellemose E; Arora T; Engelstoft MS; Asher WB; Javitch JA; Schwartz TW; Trauelsen M
    Mol Metab; 2023 Aug; 74():101757. PubMed ID: 37348738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine.
    Christensen LW; Kuhre RE; Janus C; Svendsen B; Holst JJ
    Physiol Rep; 2015 Sep; 3(9):. PubMed ID: 26381015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR119, a Major Enteroendocrine Sensor of Dietary Triglyceride Metabolites Coacting in Synergy With FFA1 (GPR40).
    Ekberg JH; Hauge M; Kristensen LV; Madsen AN; Engelstoft MS; Husted AS; Sichlau R; Egerod KL; Timshel P; Kowalski TJ; Gribble FM; Reiman F; Hansen HS; Howard AD; Holst B; Schwartz TW
    Endocrinology; 2016 Dec; 157(12):4561-4569. PubMed ID: 27779915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve.
    Ueno H; Ito R; Abe SI; Ogino H; Maruyama M; Miyashita H; Miyamoto Y; Moritoh Y; Tsujihata Y; Takeuchi K; Nishigaki N
    PLoS One; 2019; 14(9):e0222653. PubMed ID: 31525244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents.
    Luo J; Swaminath G; Brown SP; Zhang J; Guo Q; Chen M; Nguyen K; Tran T; Miao L; Dransfield PJ; Vimolratana M; Houze JB; Wong S; Toteva M; Shan B; Li F; Zhuang R; Lin DC
    PLoS One; 2012; 7(10):e46300. PubMed ID: 23056280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gs/Gq signaling switch in β cells defines incretin effectiveness in diabetes.
    Oduori OS; Murao N; Shimomura K; Takahashi H; Zhang Q; Dou H; Sakai S; Minami K; Chanclon B; Guida C; Kothegala L; Tolö J; Maejima Y; Yokoi N; Minami Y; Miki T; Rorsman P; Seino S
    J Clin Invest; 2020 Dec; 130(12):6639-6655. PubMed ID: 33196462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR40-Mediated G
    Rives ML; Rady B; Swanson N; Zhao S; Qi J; Arnoult E; Bakaj I; Mancini A; Breton B; Lee SP; Player MR; Pocai A
    Mol Pharmacol; 2018 Jun; 93(6):581-591. PubMed ID: 29572336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships.
    Paul A; Nahar S; Nahata P; Sarkar A; Maji A; Samanta A; Karmakar S; Maity TK
    Eur J Med Chem; 2024 Jan; 264():115990. PubMed ID: 38039791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Activity Relationship Study and Biological Evaluation of 2-(Disubstituted phenyl)-indole-5-propanoic Acid Derivatives as GPR40 Full Agonists.
    Zhao X; Yoon DO; Yoo J; Park HJ
    J Med Chem; 2021 Apr; 64(7):4130-4149. PubMed ID: 33769827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Updates on Free Fatty Acid Receptor 1 (GPR-40) Agonists for the Treatment of Type 2 Diabetes Mellitus.
    Rani L; Grewal AS; Sharma N; Singh S
    Mini Rev Med Chem; 2021; 21(4):426-470. PubMed ID: 33100202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus: focus on bile acid sequestrants.
    Holst JJ; McGill MA
    Clin Drug Investig; 2012 Jan; 32(1):1-14. PubMed ID: 21958333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and therapeutics of the free fatty acid receptor GPR40.
    Huang H; Dai MH; Tao YX
    Prog Mol Biol Transl Sci; 2014; 121():67-94. PubMed ID: 24373235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders.
    Guan HP; Xiong Y
    Front Pharmacol; 2022; 13():1043828. PubMed ID: 36386134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPR40 reduces food intake and body weight through GLP-1.
    Gorski JN; Pachanski MJ; Mane J; Plummer CW; Souza S; Thomas-Fowlkes BS; Ogawa AM; Weinglass AB; Di Salvo J; Cheewatrakoolpong B; Howard AD; Colletti SL; Trujillo ME
    Am J Physiol Endocrinol Metab; 2017 Jul; 313(1):E37-E47. PubMed ID: 28292762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates.
    Rady B; Liu J; Huang H; Bakaj I; Qi J; Lee SP; Martin T; Norquay L; Player M; Pocai A
    Front Endocrinol (Lausanne); 2022; 13():1061688. PubMed ID: 36482991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for GPR40 allosteric agonism and incretin stimulation.
    Ho JD; Chau B; Rodgers L; Lu F; Wilbur KL; Otto KA; Chen Y; Song M; Riley JP; Yang HC; Reynolds NA; Kahl SD; Lewis AP; Groshong C; Madsen RE; Conners K; Lineswala JP; Gheyi T; Saflor MD; Lee MR; Benach J; Baker KA; Montrose-Rafizadeh C; Genin MJ; Miller AR; Hamdouchi C
    Nat Commun; 2018 Apr; 9(1):1645. PubMed ID: 29695780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Pyrrolidine-Containing GPR40 Agonists: Stereochemistry Effects a Change in Binding Mode.
    Jurica EA; Wu X; Williams KN; Hernandez AS; Nirschl DS; Rampulla RA; Mathur A; Zhou M; Cao G; Xie C; Jacob B; Cai H; Wang T; Murphy BJ; Liu H; Xu C; Kunselman LK; Hicks MB; Sun Q; Schnur DM; Sitkoff DF; Dierks EA; Apedo A; Moore DB; Foster KA; Cvijic ME; Panemangalore R; Flynn NA; Maxwell BD; Hong Y; Tian Y; Wilkes JJ; Zinker BA; Whaley JM; Barrish JC; Robl JA; Ewing WR; Ellsworth BA
    J Med Chem; 2017 Feb; 60(4):1417-1431. PubMed ID: 28112924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.